MorphoSys AG (LTS:0NDV)
€ 66.8 0 (0%) Market Cap: 2.55 Bil Enterprise Value: 2.50 Bil PE Ratio: 0 PB Ratio: 51.84 GF Score: 59/100

MorphoSys AG at Goldman Sachs Global Healthcare Conference (Virtual) Transcript

Jun 10, 2020 / 12:50PM GMT
Release Date Price: €106.75 (-0.30%)
Graig Suvannavejh
Goldman Sachs Group, Inc., Research Division - Executive Director & Senior Equity Research Analyst

We are at the 8:50 a.m. session of the Goldman Sachs Global Healthcare Conference. My name is Graig Suvannavejh. I'm the European biotech analyst for the firm, and I also cover U.S. biopharma names as well. But I've got the pleasure this morning of hosting MorphoSys, and joining us from the company today is Jean-Paul Kress, who's Chief Executive Officer of the company. So let me thank you, Jean-Paul, for joining us. But perhaps before we go into our fireside chat, obviously, let me welcome you to your first Goldman Sachs Healthcare Conference. And obviously, we look forward to your participation in many years to come.

Questions & Answers

Graig Suvannavejh
Goldman Sachs Group, Inc., Research Division - Executive Director & Senior Equity Research Analyst

You were named CEO about a year ago, maybe a little over a year ago. And so would like to maybe start off this fireside chat in asking you how you think the year has gone. What

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot